Top Markets
Coin of the day
Hybrigenics S.A. Hybrigenics S.A.

Hybrigenics S.A.

ALHYG
Rank in Stocks #36421
Hybrigenics SA is a biotechnology firm, along with its subsidiaries,... Hybrigenics SA is a biotechnology firm, along with its subsidiaries, headquartered in Gallargues-le-Montueux, France. The company specializes in pioneering biotechnological advancements, particularly within oncology, regenerative medicine, and anti-aging therapies. Additionally, Hybrigenics is actively involved in developing technical solutions that leverage adipose tissue cells and stem cells. It operates as a subsidiary of Diagnostic Medical Systems S.A.
Share Price
$0.01155578
Last synced: 2024-07-16
Market Cap
$2.70M
Change (1 day)
2.98%
Change (1 year)
0.00%
Country
FR
Trade Hybrigenics S.A. (ALHYG)

Category

P/E ratio for Hybrigenics S.A. (ALHYG)
P/E ratio as of August 2026 TTM: -0.21
According to Hybrigenics S.A. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.21. At the end of 2022 the company had a P/E ratio of -30.02.
P/E ratio history for Hybrigenics S.A. from 2009 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -0.21 -53.49%
2023 -0.45 -98.50%
2022 -30.02 -125.80%
2021 116.34 -173.61%
2020 -158.05 521.60%
2019 -25.43 5,665.58%
2018 -0.44 -85.81%
2017 -3.11 -44.48%
2016 -5.60 -34.87%
2015 -8.60 -41.14%
2014 -14.61 -32.58%
2013 -21.67 227.99%
2012 -6.61 20.41%
2011 -5.49 59.12%
2010 -3.45 -56.30%
2009 -7.89 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -14,051.41%
US
30.62 -14,729.34%
NL
- -
CH
- -
KR
18.38 -8,882.13%
BE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.